StockData
Hyperfine, Inc. logo

Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.54−0.02 (-2.97%)

Close on Nov 18, 2026Market cap $57.79MP/E –Yield –

Hyperfine operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Hyperfine's operating income for the twelve months ending Jun 30, 2026 was -$33.62M. For fiscal 2025 it was -$37.09M. The highest annual figure on record is -$23.49M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$37.09M–
FY2024Dec 31, 2024-$43.22M–
FY2023Dec 31, 2023-$48.12M–
FY2022Dec 31, 2022-$73.87M–
FY2021Dec 31, 2021-$64.87M–
FY2020Dec 31, 2020-$23.49M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.47M–
Q1 FY2026Mar 31, 2026-$8.56M–
Q4 FY2025Dec 31, 2025-$7.67M–
Q3 FY2025Sep 30, 2025-$8.92M–
Q2 FY2025Jun 30, 2025-$9.60M–
Q1 FY2025Mar 31, 2025-$10.90M–
Q4 FY2024Dec 31, 2024-$10.77M–
Q3 FY2024Sep 30, 2024-$10.96M–
Q2 FY2024Jun 30, 2024-$10.85M–
Q1 FY2024Mar 31, 2024-$10.65M–
Q4 FY2023Dec 31, 2023-$11.63M–
Q3 FY2023Sep 30, 2023-$11.76M–
Q2 FY2023Jun 30, 2023-$11.69M–
Q1 FY2023Mar 31, 2023-$13.04M–
Q4 FY2022Dec 31, 2022-$13.63M–
Q3 FY2022Sep 30, 2022-$13.28M–
Q2 FY2022Jun 30, 2022-$23.19M–
Q1 FY2022Mar 31, 2022-$23.77M–
Q4 FY2021Dec 31, 2021-$26.09M–
Q3 FY2021Sep 30, 2021-$16.39M–
Q2 FY2021Jun 30, 2021-$14.59M–
Q1 FY2021Mar 31, 2021-$7.81M–

More Hyperfine figures

See a number that looks wrong?